Beneficient

BENF Nasdaq SEC CIK 1775734
Follow Beneficient Weekly email: filings, results

Financials

Reported figures only · latest: Q2 2027 USD · US GAAP
Net income −$22.1M −507.8% vs same quarter last year
EPS, diluted -
Operating cash flow −$10.1M +30.8% vs same quarter last year
Operating income −$39.3M −120.3% vs same quarter last year
Revenue by quarter
$4.4M
$18.7M
$12.2M
Q3 25 Q3 26 Q1 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income6 fiscal years
−$3B−$2B−$1B$0$1BFY21FY22FY23FY24FY25FY26
Show the numbers
YearNet income
FY26−$87.4M
FY25$51.2M
FY24−$2.1B
FY23−$131M
FY22−$63M
FY21−$58M
Free cash flowOperating cash flow minus capital expenditure
−$100M−$75M−$50M−$25M$0FY21FY22FY23FY24FY25FY26
Show the numbers
YearFree cash flow
FY26−$38.8M
FY25−$38.8M
FY24−$60M
FY23−$97.2M
FY22−$61.2M
FY21−$57.2M